Colorectal Cancer Is a Microbiome Disease

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide. While inherited mutations account for approximately 5-10% of CRC cases, the vast majority arise from environmental factors acting on the colonic mucosa over decades. The gut microbiome, which is in direct physical contact with the colonic epithelium, is now recognised as a central player in CRC development.

The evidence is unambiguous: specific bacterial species are enriched in colorectal tumours, certain bacteria produce toxins that directly cause the DNA mutations found in CRC, and microbiome composition predicts CRC risk and treatment response. This knowledge is rapidly translating into new screening biomarkers and prevention strategies.

Pro-Carcinogenic Bacteria

Fusobacterium nucleatum

Fusobacterium nucleatum is the bacterium most consistently associated with CRC across populations and studies. Originally an oral pathogen, F. nucleatum migrates to the colon where it adheres to cancer cells via its FadA adhesin protein binding to E-cadherin on the cell surface. Its mechanisms of carcinogenesis include:

  • Activation of the beta-catenin/Wnt signalling pathway, promoting cell proliferation
  • Suppression of anti-tumour immunity by inhibiting NK cell and T-cell function
  • Promotion of a pro-inflammatory tumour microenvironment through NF-kB activation
  • Induction of chemoresistance through autophagy pathway activation

F. nucleatum enrichment in tumour tissue is associated with worse prognosis, higher recurrence rates, and reduced response to chemotherapy.

Colibactin-Producing E. coli

Certain strains of Escherichia coli carry a genomic island called the pks island that encodes the genotoxin colibactin. Colibactin directly alkylates DNA, causing double-strand breaks and a distinctive mutational signature (SBS88). This signature has been identified in approximately 5-10% of colorectal cancer genomes, providing direct molecular evidence that this bacterial toxin initiates CRC.

Enterotoxigenic Bacteroides fragilis

Bacteroides fragilis strains that produce the metalloprotease toxin BFT (B. fragilis toxin) cause colonic epithelial cell damage, trigger inflammatory signalling through IL-17 and NF-kB pathways, and promote tumour formation in animal models. Toxigenic B. fragilis has been found enriched in the mucosa of familial adenomatous polyposis patients, suggesting a role in early CRC development.

Researchers have proposed a "driver-passenger" model of CRC: specific bacteria (drivers) initiate carcinogenesis through direct genotoxicity or chronic inflammation, while other bacteria (passengers) thrive in the altered tumour microenvironment and further promote progression.

Protective Bacteria

Not all gut bacteria promote CRC. Several species actively protect against colorectal carcinogenesis:

  • Faecalibacterium prausnitzii — the primary butyrate producer; butyrate inhibits HDAC enzymes, promoting cancer cell apoptosis while nourishing normal colonocytes
  • Roseburia species — additional butyrate producers consistently depleted in CRC patients
  • Bifidobacterium species — enhance anti-tumour immune responses and reduce intestinal inflammation
  • Lactobacillus species — produce bacteriocins with anti-tumour properties and modulate local immune function

Diet and CRC Prevention Through the Microbiome

Fibre: The Single Most Protective Dietary Factor

A 2023 umbrella review of meta-analyses concluded that dietary fibre is the single dietary factor with the strongest evidence for CRC risk reduction. Each 10g increase in daily fibre intake reduces CRC risk by approximately 10%. The primary mechanism is increased butyrate production by fibre-fermenting bacteria. Butyrate is the preferred energy source for colonocytes, maintains the mucosal barrier, suppresses inflammation, and induces apoptosis in transformed cells.

Foods That Reduce CRC Risk

  • Diverse vegetables, fruits, whole grains, and legumes (fibre and polyphenols)
  • Garlic and allium vegetables (contain organosulphur compounds with anti-cancer properties)
  • Fermented foods (introduce protective bacteria and their metabolites)
  • Cruciferous vegetables (sulforaphane activates detoxification enzymes and has anti-proliferative effects)
  • Calcium-rich foods (calcium binds secondary bile acids in the colon, reducing their genotoxic effects)

Foods That Increase CRC Risk

  • Processed meats (classified as Group 1 carcinogens by the WHO; promote N-nitroso compound formation)
  • Red meat in excess of 500g per week (promotes secondary bile acid and haem-iron-mediated oxidative damage)
  • Ultra-processed foods (emulsifiers disrupt the mucus barrier that protects colonocytes from bacterial contact)
  • Alcohol (directly damages colonic epithelial DNA and promotes dysbiosis)

Microbiome-Based CRC Screening

Gut microbiome analysis is emerging as a potential CRC screening tool. Several studies have demonstrated that faecal microbial biomarkers (particularly F. nucleatum abundance) can detect CRC with sensitivity and specificity comparable to or exceeding the faecal immunochemical test (FIT). GutIQ supports individuals in understanding their overall gut health profile, which is an essential foundation for cancer prevention through microbiome optimisation.